Added to YB: 2015-12-04
Pitch date: 2015-12-04
ALKS:US [bullish]
Alkermes plc
-40.86%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
Market Cap
$5.4B
Pitch Price
$54.11
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.95
P/E
16.35
EV/Sales
2.89
Sector
Biotechnology
Category
N/A
Show full summary:
ALKERMES PLC COM ALKS:US
A summary for this pitch has not been created yet.
Read full article (0 min)